82 related articles for article (PubMed ID: 9156564)
1. Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction.
Jung R; Ahmad-Nejad P; Wimmer M; Gerhard M; Wagener C; Neumaier M
Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):3-10. PubMed ID: 9156564
[TBL] [Abstract][Full Text] [Related]
2. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
[TBL] [Abstract][Full Text] [Related]
4. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N
Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742
[TBL] [Abstract][Full Text] [Related]
6. Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells.
Zippelius A; Lutterbüse R; Riethmüller G; Pantel K
Clin Cancer Res; 2000 Jul; 6(7):2741-50. PubMed ID: 10914719
[TBL] [Abstract][Full Text] [Related]
7. Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells.
McIntyre IG; Spreckley K; Clarke RB; Anderson E; Clarke NW; George NJ
Br J Cancer; 2000 Oct; 83(8):992-7. PubMed ID: 10993644
[TBL] [Abstract][Full Text] [Related]
8. Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Schmidt P; Thiele M; Rudroff C; Vaz A; Schilli M; Friedrich K; Scheele J
Hepatogastroenterology; 2001; 48(42):1675-9. PubMed ID: 11813599
[TBL] [Abstract][Full Text] [Related]
9. Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis.
Ishii T; Fujiwara Y; Ohnaka S; Hayashi T; Taniguchi H; Takiguchi S; Yasuda T; Yano M; Monden M
Ann Surg Oncol; 2004 Aug; 11(8):778-85. PubMed ID: 15289240
[TBL] [Abstract][Full Text] [Related]
10. Detection of peritoneal micrometastases by reverse transcriptase-polymerase chain reaction targeting carcinoembryonic antigen and cytokeratin 20 in colon cancer patients.
Aoki S; Takagi Y; Hayakawa M; Yamaguchi K; Futamura M; Kunieda K; Saji S
J Exp Clin Cancer Res; 2002 Dec; 21(4):555-62. PubMed ID: 12636102
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
12. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
[TBL] [Abstract][Full Text] [Related]
14. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
15. Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen.
Ho SB; Hyslop A; Albrecht R; Jacobson A; Spencer M; Rothenberger DA; Niehans GA; D'Cunha J; Kratzke RA
Clin Cancer Res; 2004 Sep; 10(17):5777-84. PubMed ID: 15355906
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.
Chen CC; Hou MF; Wang JY; Chang TW; Lai DY; Chen YF; Hung SY; Lin SR
Cancer Lett; 2006 Aug; 240(2):279-88. PubMed ID: 16289546
[TBL] [Abstract][Full Text] [Related]
17. Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.
Albers P; Ko Y; Wardelmann E; Schmidt D; Adam M; Vetter H; Müller SC
Anticancer Res; 2000; 20(3B):2107-11. PubMed ID: 10928161
[TBL] [Abstract][Full Text] [Related]
18. The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer.
Patel K; Whelan PJ; Prescott S; Brownhill SC; Johnston CF; Selby PJ; Burchill SA
Clin Cancer Res; 2004 Nov; 10(22):7511-9. PubMed ID: 15569981
[TBL] [Abstract][Full Text] [Related]
19. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay.
De Luca A; Pignata S; Casamassimi A; D'Antonio A; Gridelli C; Rossi A; Cremona F; Parisi V; De Matteis A; Normanno N
Clin Cancer Res; 2000 Apr; 6(4):1439-44. PubMed ID: 10778975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
